Literature DB >> 3110694

Functional deterioration of the peritoneum: does it occur in the absence of peritonitis?

K Ota, M Mineshima, N Watanabe, S Naganuma.   

Abstract

Peritoneal function in relation to the occurrence of peritonitis and the osmolarity of the dialysate was studied in 72 CAPD patients with a mean duration of treatment of 16.5 +/- 9.0 months (group 1). Data from 24 of these patients, who were on CAPD for longer than 2 years (average 28.6 +/- 4.9), were subjected to further detailed analysis (group 2). Each group consisted of two subgroups, one of patients who had experienced peritonitis and one of patients who had had no episodes of peritonitis. Results from group 1 revealed that the use of hyperosmolar bags increased in parallel with the duration of CAPD treatment even in the non-peritonitis subgroup, and that peritonitis enhanced the tendency to use hyperosmolar dialysate solutions. This phenomenon was also observed in the peritonitis subgroup of group 2, but was not apparent in the non-peritonitis subgroup of group 2 when examined as a whole: however, individual analysis revealed that some of them had a similar tendency to use hyperosmolar dialysate, as was seen in the peritonitis subgroup. These results confirm that the peritonitis impairs the ultrafiltration capability of the peritoneum. The results also suggest that the long-term use of hyperosmolar dialysate may be associated with decreased ultrafiltration, hence emphasis should be placed upon the use of hyperosmolar dialysate solutions for long-term CAPD.

Entities:  

Mesh:

Year:  1987        PMID: 3110694

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model.

Authors:  Elizabeth D Hermsen; Laurie B Hovde; John R Hotchkiss; John C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 2.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

Review 3.  Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response.

Authors:  Jose U Scher; Renuka R Nayak; Carles Ubeda; Peter J Turnbaugh; Steven B Abramson
Journal:  Nat Rev Rheumatol       Date:  2020-03-10       Impact factor: 32.286

4.  Systemically-delivered biodegradable PLGA alters gut microbiota and induces transcriptomic reprogramming in the liver in an obesity mouse model.

Authors:  Alice Chaplin; Huiyun Gao; Courteney Asase; Palanivel Rengasamy; Bongsoo Park; Danielle Skander; Gürkan Bebek; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.